Clinical Trial Update: Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of indacaterol maleate/glycopyrronium bromide in chronic obstructive pulmonary disease; the study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol maleate / glycopyrronium bromide

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-04-02